Humana will expand its use of Cohere Health’s prior authorization platform for diagnostic imaging and sleep services.. Cohere is a provider of clinical intelligence and prior authorization automation. In January 2021, Cohere and Humana began a pilot program in 12 states to improve the prior authorization process for musculoskeletal services. The program reduced prior authorization approval turnaround times, increased provider satisfaction, and enhanced care delivery for MSK services, which resulted in an expansion across all 50 states in 2022. In January 2023, Cohere’s solutions were deployed nationwide to include cardiovascular and surgical services. Cohere processes 5.5 million prior authorizations annually, impacting more than 15 million health plan members and 420,000 healthcare providers nationwide.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Is HUM a Buy, Before Earnings?
- Hospital survey weakened ‘dramatically’ in March, says TD Cowen
- Early notable gainers among liquid option names on April 16th
- Centene rises, Molina slides following Floridaâs managed Medicaid awards
- Molina Healthcare price target lowered to $410 from $440 at Wells Fargo